Soleno Therapeutics (SLNO) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 156.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.31% |
| Dec 31, 2025 | 68.70% |
| Sep 30, 2025 | 132.01% |
| Jun 30, 2025 | 47.03% |
| Mar 31, 2025 | 41.02% |
| Dec 31, 2024 | 60.41% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 19.29% |
| Mar 31, 2024 | 0.95% |
| Dec 31, 2023 | 51.06% |
| Sep 30, 2023 | -2.27% |
| Jun 30, 2023 | -32.33% |
| Mar 31, 2023 | -19.37% |
| Dec 31, 2022 | -11.03% |
| Sep 30, 2022 | 20.73% |
| Jun 30, 2022 | 15.79% |
| Mar 31, 2022 | 14.34% |
| Dec 31, 2021 | -2.66% |
| Sep 30, 2021 | 40.15% |
| Jun 30, 2021 | 38.69% |
| Mar 31, 2021 | 40.93% |
| Dec 31, 2020 | 42.25% |
| Sep 30, 2020 | 1,070.56% |
| Jun 30, 2020 | 1,113.21% |
| Mar 31, 2020 | 655.12% |
| Dec 31, 2019 | 96.66% |
| Sep 30, 2019 | 27.51% |
| Jun 30, 2019 | 83.67% |
| Mar 31, 2019 | 44.04% |
| Dec 31, 2018 | 61.39% |
| Sep 30, 2018 | 29.45% |
| Jun 30, 2018 | 18.70% |
| Mar 31, 2018 | 15.98% |
| Dec 31, 2017 | 29.05% |
| Sep 30, 2017 | -18.22% |
| Jun 30, 2017 | -69.29% |
| Mar 31, 2017 | -64.22% |
| Dec 31, 2016 | 29.04% |
| Sep 30, 2016 | 39.56% |